SCHEMBL4912943

SCHEMBL4912943

CN(C)CCNc1cnnc2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 2/20 0.59
SLC2A1 P11166 2/20 0.57
POLB P06746 3/20 0.51
RAD52 P43351 3/20 0.51
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
ACP1 P24666 2/20 0.50
GAA P10253 1/20 0.50
ALPG P10696 1/20 0.50
TOP2A P11388 2/20 0.49
TLR9 Q9NR96 1/20 0.46
NPC1 O15118 1/20 0.46
APOBEC3A P31941 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
PABPC1 P11940 1/20 0.44
EIF4H Q15056 1/20 0.44
SMARCA2 P51531 1/20 0.44
NQO1 P15559 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4913166 0.77 HTR1A (0.73) NCF1SLC2A1POLBRAD52KDM4E
SCHEMBL4912004 0.75 ALDH1A1 (0.45) NCF1SLC2A1POLBALDH1A1KMT2A
SCHEMBL899153 0.75 NCF1 (1.00) NCF1SLC2A1POLBRAD52KDM4E
SCHEMBL9616073 0.74 CYP1A2 (0.53) ALDH1A1ACP1NPC1RAB9AHRH3
SCHEMBL18879049 0.73 GPR3 (0.44) NCF1SLC2A1KDM4EALDH1A1NPC1
SCHEMBL12402667 0.72 SLC2A1 (1.00) NCF1SLC2A1POLBRAD52KDM4E
SCHEMBL237848 0.72 RET (0.39) NCF1SLC2A1POLBRAD52KDM4E
SCHEMBL20265361 0.70 ALDH1A1 (0.47) KDM4EALDH1A1GAANPC1RAB9A
SCHEMBL19841858 0.69 IDO1 (0.43) KDM4EALDH1A1ACP1NPC1RAB9A
SCHEMBL11669132 0.69 CA12 (0.61) NCF1SLC2A1POLBRAD52KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080045538-A1 Nitro and amino substituted topoisomerase agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2008-02-21 US disclosed
US-6992089-B2 Nitro and amino substituted topoisomerase agents RUTGERS, THE UNIVERSITY OF NEW JERSEY (US) 2006-01-31 US disclosed
US-20040102443-A1 Nitro and amino substituted topoisomerase agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2004-05-27 US disclosed
WO-2004014906-A2 NITRO AND AMINO SUBSTITUTED DIBENZONAPHTHYRIDINES AS TOPOISOMERASE AGENTS RUTGERS, THE STATE UNIVERSITY (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045538-A1 Nitro and amino substituted topoisomerase agents TOP1, TOP2A, TOP2B NCF1 250/4885SLC2A1 3449/4885POLB 30/4885
US-20040102443-A1 Nitro and amino substituted topoisomerase agents TOP1, TOP2A, TOP2B NCF1 159/4885SLC2A1 3228/4885POLB 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.